Teva CEO Levin to Step Down After Reported Board Feud By David Wainer - Oct 30, 2013 7:10 AM ET
Teva Pharmaceutical Industries Ltd. (TEVA) Chief Executive Officer Jeremy Levin quit after less than 18 months on the job, two days after denying he would step down amid a reported feud with Chairman Phillip Frost. Levin and Teva’s board agreed he would resign, the company said in a statement today. The directors formed a committee to find a successor and Chief Financial Officer Eyal Desheh will serve as interim CEO, Petach Tikva, Israel-based Teva said
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.